Business Acquisitions

3 Months Ended

Mar. 31, 2016

Business Acquisitions [Abstract]

Business Acquisitions [Text Block]

4.    Business Acquisitions

Roper completed two business acquisitions in the first quarter of 2016, with an aggregate purchase price of $264 million using cash on hand.  The results of operations of the acquired companies have been included in Roper's consolidated results since the date of each acquisition.  Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on Roper's consolidated results of operations individually or in aggregate.

On January 7, 2016, Roper acquired 100% of the shares of CliniSys Group, Ltd. ("CliniSys"), a provider of clinical laboratory software headquartered in the United Kingdom.

On March 17, 2016, Roper acquired the assets of PCI Medical, LLC, a provider of medical probe and scope disinfection products.

Both acquisitions are reported in the Medical & Scientific Imaging segment and were acquired to enhance existing platforms and product lines.

The Company recorded $145 million in goodwill and $141 million of other identifiable intangibles in connection with the acquisitions; however, purchase price allocations are preliminary pending final intangible valuations and tax-related adjustments.  Of the $141 million intangible assets acquired, $10 million was assigned to trade names that are not subject to amortization.  The remaining $131 million of acquired intangible assets have a weighted average useful life of 17 years.  The amortizable intangible assets include customer relationships of $95 million (20 year weighted average useful life) and unpatented technology of $36 million (8 year weighted average useful life).